Adrenoceptors in the Lower Urinary Tract-Reference-Cited by-同舟云学术

Adrenoceptors in the Lower Urinary Tract

Published:2023 Issue: Volume: Page:
ISSN:0171-2004
Container-title:Handbook of Experimental Pharmacology
language:
Short-container-title:

Author:

Hennenberg Martin,Michel Martin C.

Publisher

Springer Berlin Heidelberg

Link

https://link.springer.com/content/pdf/10.1007/164_2023_678

Reference165 articles.

1. Akiyama K et al (1999) KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model. J Pharmacol Exp Ther 291(1):81–91

2. Akiyama K et al (2001) Effect of KMD-3213, an alpha1A-adrenoceptor antagonist, on the prostatic urethral pressure and blood pressure in male decerebrate dogs. Int J Urol 8(4):177–183

3. Alexandre EC et al (2016) Mirabegron relaxes urethral smooth muscle by a dual mechanism involving beta3 -adrenoceptor activation and alpha1 -adrenoceptor blockade. Br J Pharmacol 173(3):415–428

4. Andersson K-E, Michel MC (2011) Urinary tract. In: Hofmann FB (ed) Handbook of experimental pharmacology, vol 202. Springer Verlag, Heidelberg, p 577

5. Aro E et al (2015) Is there a peripheral site of action contributing to the voiding effects of alpha(2)-adrenoceptor agonists and antagonists? World J Urol 33(3):433–440

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic phenotypic shifts and M2 receptor downregulation in bladder smooth muscle cells induced by mirabegron;Frontiers in Pharmacology;2024-07-24

2. Ligand–Receptor Interactions and Structure–Function Relationships in Off-Target Binding of the β3-Adrenergic Agonist Mirabegron to α1A-Adrenergic Receptors;International Journal of Molecular Sciences;2024-07-07

3. Effects of carvedilol on human prostate tissue contractility and stromal cell growth pointing to potential clinical implications;Pharmacological Reports;2024-06-11

4. A Novel ADRA1A Missence Variant (c.939G > T) in Two Related Patients with Anejaculation: Case Report;Indian Journal of Clinical Biochemistry;2024-05-28

5. Isoform‐independent promotion of contractility and proliferation, and suppression of survival by with no lysine/K kinases in prostate stromal cells;The FASEB Journal;2024-04-09